Chronolife is a French medtech startup founded in 2015 that offers turnkey solutions for remote health monitoring. The company's slogan emphasizes its focus on providing services for the preventive monitoring of patients and at-risk individuals. Utilizing a comprehensive, open platform, Chronolife leverages best-in-class wearables and next-gen third party devices to offer precise and timely health information. This enables proactive interventions to prevent potential health complications.
The startup's last investment round was a Seed Round in December 2019. The investors in this round included Celeste Management, iBionext, and Adrea. With a clear focus on the medical devices industry, Chronolife's innovative approach aims to revolutionize remote health monitoring for not only patients but also individuals in high-risk professions and top-level athletes.